177lu-psma i&t for patients with psma-positive mcrpc
Published 2 years ago • 86 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:28
vision: 177lu-psma-617 in psma-positive mcrpc
-
3:56
vision: 177lu-psma-617 in psma-positive mcrpc
-
3:30
radionuclide conjugates 225ac-j591 and 177lu-psma-i&t for mcrpc
-
3:07
psma-trt, 225ac-j591 and 177lu-psma i&t in mcrpc
-
1:35
vision: safety analysis of 177lu-psma-617 in mcrpc
-
2:24
eclipse - a randomized phase 3 trial for 177-lu-psma-i&t in patients with mcrpc
-
3:03
vision: tolerability of 177lu-psma-617 by treatment exposure in patients with mcrpc
-
4:48
vision: lu-177-psma-617 in mcrpc
-
18:26
psma & newly-diagnosed #prostatecancer | markscholzmd #alexscholz #pcri
-
6:43
does sugar feed prostate cancer? does fatty/adipose tissue attract cancer? | mark moyad, md, mph
-
1:15:48
advanced #prostatecancer treatments extended q a | #markscholzmd & #markmoyadmd #pcri
-
5:30
fractionated dose 177lu-psma-617 in patients with mcrpc
-
0:57
real-world outcomes of 177lu-psma-617 in mcrpc
-
3:30
how to administer the investigational radiopharmaceutical 177lu-psma-i&t
-
1:08
psma imaging pre- and post-177lu-psma-617 treatment in mcrpc
-
11:01
lutetium-177: psma guided treatment | #prostatecancer | #markscholzmd | #pcri
-
1:00
is there are role for 177lu-psma-617 in earlier lines of treatment for mcrpc?
-
5:37
177lu-psma-617 for the early treatment of prostate cancer
-
1:02
dr. gafita on prognostic models for treatment with 177lu-psma-617 in mcrpc
-
5:27
177lu-psma-617 radionuclide therapy in mcrpc
-
3:25
highlights on lu-psma-617 in taxane-naive patients with mcrpc: the psmafore study
-
5:06
psmaddition: 177lu-psma-617 plus soc vs. soc alone in metastatic hormone-sensitive prostate cancer